When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides Orthopedic Use of BPC 157 Sports Med Review FDA Removes Key Peptides from Category 2: What This Means for You FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog